Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Target enrollment reached in ASCENT trial of DN-101

Dec. 29, 2003

Exelixis files IND for phase III trial of XL-119

Dec. 29, 2003

Esters of camptothecins with enhanced anticancer activity described in recent patent

Dec. 29, 2003

COX17 as a novel target for NSCLC

Dec. 23, 2003

Mitotic kinesin KSP inhibitors reported by Cytokinetics and GlaxoSmithKline

Dec. 23, 2003

Photobarr PDT recommended for approval in E.U.

Dec. 23, 2003

Array BioPharma and AstraZeneca to develop MEK program for oncology

Dec. 23, 2003

Alexion and XOMA collaborate on c-MPL agonist antibody development

Dec. 23, 2003

Highlights from the 2003 AACR-NCI-EORTC International Conference available on the LifeSci Channel

Dec. 23, 2003

Clinical effects of PKC-412 in acute myeloid leukemia

Dec. 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...